ZyVersa Therapeutics, Inc. (ZVSA) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 742.22M | 347.9M | 995.53K | 549.07K | 2.11M | 1.72M | 390.42K | 641.39K | 2.9M | 3.35M | 2.01M | 1.12M | 2.83M | 6.36M | 1.14M | 1.75M | 1.25M | 1.18M | 0 | 0 |
| Cash & Short-Term Investments | 302.66M | 101.78M | 527.98K | 72.09K | 1.61M | 1.53M | 122.92K | 119.49K | 2.03M | 3.14M | 1.58M | 228.69K | 1.28M | 5.9M | 602.75K | 328.81K | 347.93K | 928.39K | 0 | 0 |
| Cash Only | 302.66M | 101.78M | 527.98K | 72.09K | 1.61M | 1.53M | 122.92K | 119.49K | 2.03M | 3.14M | 1.58M | 228.69K | 1.28M | 5.9M | 602.75K | 328.81K | 347.93K | 928.39K | 0 | 0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 439.56M | 246.12M | 467.56K | 476.98K | 498.78K | 184.87K | 267.49K | 521.91K | 866.48K | 215.46K | 426.52K | 886.91K | 1.56M | 460.35K | 540.57K | 1.42M | 903.56K | 0 | 0 | 0 |
| Total Non-Current Assets | 0 | 0 | 44.73K | 19.09M | 18.88M | 18.88M | 19.03M | 18.83M | 18.75M | 18.76M | 30.85M | 30.87M | 112.12M | 112.14M | 1.2M | 189.19K | 251.79K | 75.96M | 0 | 0 |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.73K | 4.33K | 14.77K | 40.61K | 66.03K | 91.06K | 115.7K | 19.93K | 22.53K | 25.13K | 27.73K | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | 0.56x | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.9M | 11.9M | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 18.65K | 18.65M | 18.65M | 18.65M | 18.65M | 18.65M | 18.65M | 30.81M | 30.81M | 100.09M | 100.09M | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 75.75M | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 44.73K | 19.07M | 227.33K | 235.71K | 385.61K | 178.48K | 98.48K | 98.48K | 0 | 0 | 46.66K | 46.66K | 1.18M | 166.66K | 226.66K | 213.17K | 0 | 0 |
| Total Assets | 742.22M | 347.9M | 1.04M | 19.64M | 20.99M | 20.6M | 19.42M | 19.47M | 21.65M | 22.11M | 32.85M | 31.99M | 114.95M | 118.51M | 2.35M | 1.94M | 1.5M | 77.14M | 0 | 0 |
| Asset Turnover | - | - | - | - | - | 0.00x | - | - | - | 0.00x | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 3436.83% | 1588.89% | -94.64% | 0.88% | -3.07% | -6.85% | -40.87% | -39.13% | -81.17% | -81.34% | 1300.27% | 1552.21% | 7546.82% | 53.62% | - | - | - | - | - | - |
| Total Current Liabilities | 14.87B | 12.73B | 12.77M | 12.69M | 12M | 11.23M | 11.54M | 9.99M | 9.58M | 10.19M | 11.71M | 10.48M | 8.58M | 8.19M | 14.15M | 17.16M | 15.42M | 276.83K | 0 | 0 |
| Accounts Payable | 10.24M | 10.12M | 9.81M | 9.77M | 9.6M | 9.34M | 9.28M | 8.32M | 8.13M | 8.43M | 8.9M | 8.14M | 6.38M | 6.03M | 6.5M | 4.2M | 3.23M | 0 | 0 | 0 |
| Days Payables Outstanding | - | - | - | - | - | 65.7K | 467.2K | 287.77K | 72.18K | 306.59K | 301.5K | 254.19K | 214.73K | 221.69K | 189.47K | 130.19K | 111.97K | - | - | - |
| Short-Term Debt | 1.2B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.66K | 34.35K | 59.63K | 84.51K | 108.76K | 3.96M | 9.19M | 9.18M | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.08K | 13.77K | 15.47K | 0 | 0 | 0 |
| Other Current Liabilities | 13.66B | 12.72B | 7.26K | 7.26K | 570.44K | 854.7K | 170.53K | 29.23K | 59.23K | 1.09M | 538.79K | 624.28K | 7.33M | 1.36M | 2.79M | 3.22M | 2.81M | 276.83K | 0 | 0 |
| Current Ratio | 0.05x | 0.03x | 0.08x | 0.04x | 0.18x | 0.15x | 0.03x | 0.06x | 0.30x | 0.33x | 0.17x | 0.11x | 0.33x | 0.78x | 0.08x | 0.10x | 0.08x | 4.26x | - | - |
| Quick Ratio | 0.05x | 0.03x | 0.08x | 0.04x | 0.18x | 0.15x | 0.03x | 0.06x | 0.30x | 0.33x | 0.17x | 0.11x | 0.33x | 0.78x | 0.08x | 0.10x | 0.08x | 4.26x | - | - |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 851.66K | 851.66K | 851.66K | 854.62K | 854.62K | 844.91K | 844.91K | 1.44M | 1.44M | 9.28M | 10.32M | 0 | 0 | 0 | 3.38M | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 851.66K | 851.66K | 851.66K | 854.62K | 854.62K | 844.91K | 844.91K | 1.44M | 1.44M | 9.28M | 10.32M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.38M | 0 | 0 |
| Total Liabilities | 14.87B | 12.73B | 12.77M | 13.54M | 12.86M | 12.08M | 12.4M | 10.85M | 10.43M | 11.04M | 13.15M | 11.93M | 17.86M | 18.51M | 14.15M | 17.16M | 15.42M | 3.65M | 0 | 0 |
| Total Debt | 1.2B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.66K | 34.35K | 59.63K | 84.51K | 108.76K | 3.96M | 9.19M | 9.18M | 0 | 0 | 0 |
| Net Debt | 897.34M | -101.78M | -527.98K | -72.09K | -1.61M | -1.53M | -122.92K | -119.49K | -2.03M | -3.13M | -1.54M | -169.07K | -1.19M | -5.79M | 3.36M | 8.86M | 8.84M | -928.39K | 0 | 0 |
| Debt / Equity | - | - | - | - | - | - | - | - | - | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -9.85x | -3.23x | -156.27x | -16.01x | -18.88x | -9.32x | -17.24x | - | -27986.50x | - | -13822.28x | -16400.64x | - | -108.05x | -52.24x | -13.41x | -21.30x | -8.62x | -7.34x | - |
| Total Equity | -14.12B | -12.39B | -11.73M | 6.1M | 8.13M | 8.52M | 7.03M | 8.62M | 11.22M | 11.07M | 19.7M | 20.06M | 97.1M | 99.99M | -11.8M | -15.22M | -13.91M | 73.49M | 0 | 0 |
| Equity Growth % | -173823.09% | -145545.47% | -266.86% | -29.24% | -27.56% | -23.1% | -64.34% | -57.03% | -88.44% | -88.92% | 266.95% | 231.8% | 797.87% | 36.06% | - | - | - | - | - | - |
| Book Value per Share | -1.74 | -2.08 | -0.15 | 0.13 | 2.62 | 7.85 | 7.11 | 10.32 | 18.00 | 27.33 | 222.62 | 393.24 | 3722.95 | 3853.64 | -253.53 | -326.99 | -298.88 | 2564.79 | - | - |
| Total Shareholders' Equity | -14.12B | -12.39B | -11.73M | 6.1M | 8.13M | 8.52M | 7.03M | 8.62M | 11.22M | 11.07M | 19.7M | 20.06M | 97.1M | 99.99M | -11.8M | -15.22M | -13.91M | 73.49M | 0 | 0 |
| Common Stock | 1.62M | 809K | 1.62K | 487 | 257 | 251 | 107 | 83 | 83 | 405 | 4.35K | 2.37K | 922 | 902 | 242 | 242 | 242 | 248 | 0 | 0 |
| Retained Earnings | -139.38B | -137.58B | -136.91M | -117.1M | -114.89M | -112.63M | -111.21M | -108.81M | -106.05M | -103.22M | -89.88M | -86.98M | -8.47M | -4.92M | -62.34M | -58.65M | -56.65M | -2.26M | 0 | 0 |
| Treasury Stock | 0 | 0 | 0 | -7.17K | -7.17K | -7.17K | -7.17K | -7.17K | -7.17K | -7.17K | -7.17K | -7.17K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |